StockData
Parabilis Medicines, Inc. logo

Parabilis Medicines, Inc. (PBLS) stock

PBLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$28.25−0.20 (-0.70%)

Close on Nov 17, 2026Market cap $3.49BP/E –Yield –

Parabilis Medicines gross margin

Gross margin is gross profit as a percentage of revenue.

No gross margin figures for Parabilis Medicines

Parabilis Medicines has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Parabilis Medicines figures

See a number that looks wrong?